We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

111 hedge funds and large institutions have $635M invested in Momenta Pharmaceuticals, Inc. in 2013 Q2 according to their latest regulatory filings, with 111 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $10.5M | Put options by funds: $4.69M

Holders
111
Holders Change
+111
Holders Change %
–
% of All Funds
3.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
111
Increased
–
Reduced
–
Closed
–
Calls
$10.5M
Puts
$4.69M
Net Calls
+$5.83M
Net Calls Change
+$5.83M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$76.1M +$66.6M +5,050,000 New
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$56.4M +$49.4M +3,744,275 New
SCM
3
Scopia Capital Management
New York
$55.8M +$48.9M +3,707,176 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$49.7M +$43.5M +3,297,780 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$41.8M +$36.6M +2,775,604 New
BFA
6
BlackRock Fund Advisors
California
$40.3M +$35.3M +2,673,622 New
BIT
7
BlackRock Institutional Trust
California
$21.1M +$18.5M +1,399,206 New
Primecap Management
8
Primecap Management
California
$21.1M +$18.5M +1,399,000 New
State Street
9
State Street
Massachusetts
$20.4M +$17.9M +1,356,661 New
PAI
10
Palo Alto Investors
California
$17.7M +$15.5M +1,175,076 New
DCM
11
Discovery Capital Management
Connecticut
$15.3M +$13.4M +1,018,513 New
Citadel Advisors
12
Citadel Advisors
Florida
$14.4M +$12.7M +959,053 New
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$13.9M +$12.2M +923,602 New
SAM
14
Sectoral Asset Management
Quebec, Canada
$12.7M +$11.2M +846,196 New
CCM
15
Camber Capital Management
Massachusetts
$12M +$10.6M +800,000 New
Northern Trust
16
Northern Trust
Illinois
$10.9M +$9.56M +724,672 New
Millennium Management
17
Millennium Management
New York
$8.9M +$7.8M +590,935 New
Bank of New York Mellon
18
Bank of New York Mellon
New York
$8.01M +$7.02M +532,104 New
AQR Capital Management
19
AQR Capital Management
Connecticut
$7.77M +$6.81M +516,084 New
BA
20
BlackRock Advisors
Delaware
$7.33M +$6.43M +486,899 New
Goldman Sachs
21
Goldman Sachs
New York
$6.71M +$5.88M +445,708 New
BM
22
Bridger Management
New York
$6.56M +$5.75M +435,647 New
VOYA Investment Management
23
VOYA Investment Management
Georgia
$6.31M +$5.53M +418,810 New
SO
24
STRS Ohio
Ohio
$6.25M +$5.48M +415,008 New
Axa
25
Axa
France
$5.35M +$4.69M +355,246 New
1
2 3 4 5

MNTA Hedge Fund Activity: Q2 2013 in Review

111 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q2 2013, worth a combined $635M.

Buyers outnumbered sellers: 111 funds opened new MNTA positions and 0 closed out — a net gain of 111 holders — while 0 added to existing stakes and 0 trimmed.

  • 111 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $635M of Momenta Pharmaceuticals, Inc. stock for Q2 2013.
  • 111 funds opened new Momenta Pharmaceuticals, Inc. positions in Q2 2013 and 0 closed out, a net change of +111 holders.

Based on aggregated 13F filings for Q2 2013.